Code | 31211 | ||||||||||
MA number | 27/0020/12-S | ||||||||||
Product Form: | tbl plg 21x3 mg (blis.PVC/PCTFE/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Egis Pharmaceuticals PLC, Hungary | ||||||||||
Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 20.01.2012 |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 05.06.2018 |